(Q37240698)

English

Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study

scientific article published on 06 July 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

Emelia J. Benjamin

5

object named as

Emelia J Benjamin

0 references

Henri Wallaschofski

9

object named as

Henri Wallaschofski

0 references

Vanessa Xanthakis

object named as

Vanessa Xanthakis

3

0 references

object named as

Robin Haring

1

0 references

Lisa M Sullivan

object named as

Lisa Sullivan

7

0 references

Ramachandran S. Vasan

object named as

Ramachandran S Vasan

10

0 references

8

object named as

Matthias Nauck

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

6

object named as

Naomi M Hamburg

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Danielle M Enserro

2

object named as

Danielle Enserro

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Gary F Mitchell

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

6 July 2016

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 and Inflammation in CKD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

FGF-23: More than a regulator of renal phosphate handling?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Arterial stiffness and cardiovascular events: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

Multipoint quantitative-trait linkage analysis in general pedigrees

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

6 September 2017

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

14 September 2017

Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

14 September 2017

FGF23 beyond mineral metabolism: a bridge to cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015386

3 September 2018

An investigation of coronary heart disease in families. The Framingham offspring study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27385427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/27385427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/27385427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Sleep Heart Health Study: design, rationale, and methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/27385427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions

1 reference

https://pubmed.ncbi.nlm.nih.gov/27385427

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/JAHA.116.003486

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37240698&oldid=2154393590"